<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Cardiovascular Pathology</title>
    <link rel="stylesheet" href="../../../css/main.css">
    <link rel="stylesheet" href="../notes_pages.css">
    <link rel="stylesheet" href="cv_styles.css">
    <style type="text/css">
    </style>
</head>
<body>
    <h1>Cardiovascular Pathology</h1>
    <hr><br>
    <div class="ToC">
        <span id="ToC">Table of Contents</span><br>
        <ol class="ToC">
            <li>Systemic Disease
                <ol>
                    <li><a href="#htn">Hypertension</a></li>
                    <li><a href="#hld">Hyperlipidemia</a></li>
                </ol>
            </li>
            <li>Heart Diseases
                <ol>
                    <li><a href="#ihd">Ischemic Heart Disease (IHD)</a></li>
                        <ol>
                            <li><a href="#angina">Angina Pectoris</a>
                                <ol>
                                    <li><a href="#stable_angina">Stable Angina/Chronic Coronary Syndrome</a></li>
                                    <li><a href="#unstable_angina">Unstable Angina</a></li>
                                    <li><a href="#vaso_angina">Prinzmetal (Vasospastic) Angina</a></li>
                                </ol>
                            </li>
                            <li><a href="#mi">Myocardial Infarction</a>
                                <ol>
                                    <li><a href="#stemi">STEMI</a></li>
                                    <li><a href="#nstemi">NSTEMI</a></li>
                                </ol>
                            </li>
                            <li>Coronary Steal Syndrome</li>
                            <li>Sudden Cardiac Death</li>
                            <li>Chronic Ischemic Heart Disease</li>
                        </ol>
                    <li><a href="#hf">Heart Failure</a>
                        <ol>
                            <li><a href="#lhf">Left-sided Heart Failure</a></li>
                            <li><a href="#rhf">Right-sided Heart Failure</a></li>
                        </ol>                        
                    </li>
                    <li>Arrhythmias</li>
                    <li>Rheumatic Fever</li>
                    <li>Endocarditis</li>
                    <li>Pericarditis</li>
                    <li>Myocarditis</li>
                    <li>Cardiac Tamponade</li>
                </ol>
            </li>
            <li>Valvular Diseases</li>
            <li>Vascular Diseases
                <ol>
                    <li><a href="#athero">Atherosclerosis</a></li>
                </ol>
            </li>
        </ol>
    </div>

    <h2 id="htn">Hypertension</h2>
    <p><b>Hypertension</b> (<b>HTN</b>) is defined as persistent systolic BP &ge;&nbsp;130&nbsp;mmHg and/or diastolic BP &ge;&nbsp;80&nbsp;mmHg. HTN can be classified by severity or etiology.</p>
    <div class="ind">
        <u>Severity</u>:
        <ul>
            <li>Pre-HTN: 120-139&nbsp;mmHg or 80-89&nbsp;mmHg</li>
            <li><b>Stage 1</b>: 140-159&nbsp;mmHg or 90-99&nbsp;mmHg</li>
            <li><b>Stage 2</b>: &ge;&nbsp;160&nbsp;mmHg or &ge;&nbsp;100&nbsp;mmHg</li>
            <li><b>Hypertensive urgency</b>: severe HTN (&ge;&nbsp;180/&ge;&nbsp;120) without acute end-organ damage</li>
            <li><b>Hypertensive emergency</b>: severe HTN wiht evidence of acute end-organ damage (e.g., encephalopathy, stroke, retinal hemorrhage and exudates, papilledma, MI, HF, aortic dissection, kidney injury, microangiopathic hemolyic anemia, eclampsia)</li>
        </ul>
        <br>
        <u>Etiology</u>:
        <ul>
            <li><b>Primary (essential)</b>: accounts for 90% of HTN, no identifiable cause; however, it tends to be familial and likely represetns an intersection of genetics with other factors, such as excessive salt intake and increased adrenergic teratogenesis</li>
            <li><b>Secondary</b>: &uarr; systemic arterial pressure as a result of other identifable conditions
                <ul>
                    <li>Renal
                        <ul>
                            <li>Renal artery stenosis</li>
                            <li>Renal parenchymal disease</li>
                        </ul>
                    </li>
                    <li>Drug-induced
                        <ul>
                            <li>Oral contraceptives (OCP)</li>
                            <li>Glucocorticoids</li>
                            <li>Phenylephrine</li>
                            <li>NSAIDs</li>
                        </ul>
                    </li>
                    <li>Endocrine
                        <ul>
                            <li><i>Pheochromocytoma</i> &#x2012; triad of HTN, diaphoresis, and tachycardia</li>
                            <li><i>Primary aldosteronism (Conn Syndrome)</i> &#x2013; aldosterone&#x2011;producing tumor causes triad of <u>HTN</u>, <u>hypokalemia</u>, and <u>metabolic alkalosis</u></li>
                            <li>Hyperthyroidism</li>
                            <li>Cushing syndrome</li>
                        </ul>
                    </li>
                    <li>Vascular
                        <ul>
                            <li>Coarcation of the aorta</li>
                            <li>Fibromuscular dysplasia</li>
                        </ul>
                    </li>
                </ul>
            </li>
        </ul>
    </div>
    <br>
    <p><b><u>Risk factors</u></b>: &uarr; age, obesity, diabetes, physical inactivity, excess salt intake, ciagarette, family history; Af. Am. > Caucasian > Asian</p>
    <p><b><u>Treatment</u></b>:
        <ul>
            <li>1&deg; HTN: lifestyle modification, medication (diuretics, &beta;&#x2011;adrenergic antagonists, <a href="cv_pharm.html#ace_inh">ACE inhibitors</a>, <a href="cv_pharm.html#arb">angiotensin receptor blockers</a> (ARBs), calcium channel blockers, or &alpha;&#x2011;adrenergic antagonists)</li>
            <li>2&deg; HTN: Treat the underlying cause. Can include weight loss, sodium restriction, smoking cessation, eexercise, &darr; alcohol intake, and medications</li>
        </ul>
    </p>
    <p><b><u>Complications</u></b>:
        <ul>
            <li>Cardiac: CAD, LVH, heart failure, artrial fibrillation</li>
            <li>Large arterial: aortic dissection, aortic aneurysm</li>
            <li>Neurologic: stroke</li>
            <li>Renal: chronic kidney disease</li>
            <li>Opthalmologic: retinopathy</li>
        </ul>
    </p>

    <h2 id="hld">Hyperlipidemia</h2>
    <p><b>Hyperlipidemia</b> (<b>HLD</b>) is defined as having elevated triglycerides (>&nbsp;150&nbsp;mg/dL) and cholesterol (>&nbsp;200&nbsp;mg/dL).<sup>[3]</sup> Signs of hyperlipidemia can include:
        <ul>
            <li>xanthomas: plaques or nodules composed of lipid-laden histiocytes in skin, especially the eyelids (xanthelasma)</li>
            <li>tendinous xanthomas: lipid deposits in tendons, especiallly Achilles</li>
            <li>cornea arcus: lipid deposits in cornea. Commonly in elderly (arcus senilis), but appears earlier in life wiht hypercholesterolemia</li>
        </ul>
    </p>
    <div class="figure" style="width: 50%;">
        <img src="img/hyperlipidemia.png" alt="Signs of hyperlipidemia">
        <span class="title">Figure 1. Signs of Hyperlipidemia.</span> (A)&nbsp;Lipid-laden histiocytes in skin. (B)&nbsp;Xanthelasma. (C)&nbsp;Lipid deposits in tendon. (D)&nbsp;Arcus senilis. [source: First Aid Step 1 (2020)]
    </div>
    <p><b><u>Etiology</u></b>: Usually multifactorial, secondary to other causes
        <ul>
            <li>Lifestyle &#x2012; high intake of saturated &/ trans fats, physical inactivity</li>
            <li>Medications &#x2012; high-dose diuretics, cyclosporine, amiodarone, steroids, protease inhibitors</li>
            <li>Medical conditions &#x2012; eating disorders (e.g., anorexia), cholestatic liver disease (e.g, PBC, biliary obstruction), obesity, nephrotic syndrome, hypothyroidism, Cushing syndrome, pregnancy</li>
        </ul>
    </p>
    <p><b><u>Treatments</u></b>: lipid-lower agents
        <ul>
            <li>HMG-CoA reductase (atorvastatin, simvastatin, etc.) &#x2012; primarily for lowering LDL</li>
            <li>Bile acid resins (cholestyramine, colestipol, colesevelam)</li>
            <li>Eztimibe</li>
            <li>Fibrates (gemfibrozil, bezafibrate, fenofibrate) &#x2012; primarily for lower triglycerides; careful when using w/ HMG-CoA reductase inhibitors b/c 50% chance of rhabdomyolysis</li>
            <li>Niacin</li>
            <li>PCSK9 inhibitors</li>
            <li>Fish oil and marine omega-3 fatty acids</li>
        </ul>
    </p>
    <p><b><u>Complications</u></b>: Hepatic steatosis, hypertriglyceridemia-induced pancreatitis,<sup>[3]</sup> <a href="#athero">atherosclerosis</a> (& related CV events)</p>

    <h2 id="ihd">Ischemic Heart Disease (IHD)</h2>
    <p><b>Ischemic heart disease</b> (<b>IHD</b>) occurs when myocardial oxygen demand exeeds oxygen supply. While this often involves an interruption of arterial blood flow to the heart, such as atherosclerotic narrowing of coronary a.a. (called coronary artery disease, CAD), it may also be a consequence of profound anemia.</p>
    <p>Risk factors include: HTN, family hx, smoking, hypercholesterolemia (LDL >&nbsp;160&nbsp;mg/dL or HDL <&nbsp;35&nbsp;mg/dL), diabetes mellitus, age (M&nbsp;>&nbsp;45 or F&nbsp;>&nbsp;55/postmenopausal), tobacco.</p>
    <p>IDH can present as angina pectoris or myocardial infarction (MI). Angina pectoris can be divided into 3 subtypes:</p>
    <ul>
        <li>Stable angina,</li>
        <li>Unstable angina, and</li>
        <li>Prinzmetal (vasospastic) angina.</li>
    </ul>
    <p style="margin-top: 0em;">MI can be divided into ST-segment elevation MI (STEMI) or non-STEMI (NSTEMI). The term <b>acute coronary syndrome</b> (<b>ACS</b>) refers to unstable angina and both types of MI.</p>
    <div style="width: 70%; margin: 0 auto;">
        <b>Table 1. Classification of Angina & ACS</b>
        <table>
            <tr>
                <th width="33%">Angina Pectoris</th>
                <th width="33%">Acute Coronary Syndrome (ACS)</th>
                <th width="34%">Chronic Coronary Syndrome</th>
            </tr>
            <tr>
                <td>Stable<br>Vasospastic<br>Unstable</td>
                <td>Unstable angina<br>STEMI<br>NSTEMI</td>
                <td>Same as stable angina</td>
            </tr>
        </table>
    </div>

    <h3 id="angina">Stable Angina (Chronic coronary syndrome)</h3>
    <p><b>Stable angina</b> typically presents as predictable exertional chest pain, relieved by rest, in older men over a period of 2 months. The pain radiates over the left arm and is associated with dyspnea (shortness of breath, SOB). Labs show normal troponin, and normal ECG.</p>
    <p><b><u>Pathophysiology</u></b>: stable plaque w/ vessels (typically coronary a.a.) unable to dilate adequately</p>
    <p><b><u>Risk factors</u></b>: diabetes, HTN</p>
    <p><b><u>Treatments</u></b>: aspirin, statins, anti-anginal meds (e.g., &beta;&#x2011;blockers, Ca blockers, &pm; nitroglycerin)</p>
    <div class="ind arrows">
        &#8627;&nbsp;Aspirin as blood-thinner to reduce chance of clotting<br>
        &#8627;&nbsp;Statins to lower LDL<br>
        &#8627;&nbsp;&beta;&#x2011;blockers to decrease HR and contractility &Rightarrow; &darr; cardiac output and O<sub>2</sub> consumption<br>
        &#8627;&nbsp;Ca blockers to decrease muscle tone/contractility (DHP&#x2011;type on vascular smooth muscle, non&#x2011;DHP on cardiac muscle)<br>
        &#8627;&nbsp;Nitrates are smooth muscle relaxants &Rightarrow; vasodilation
    </div>

    <h3 id="unstable_angina">Unstable angina</h3>
    <p><b>Unstable angina</b> can present <i>new</i> angina occuring <i>at rest</i> <u>or</u> change in symptoms <u>without</u> elevated lab works (troponin, D-dimers, etc.). ECG may be normal, ST depression, or T-wave inversions.</p>
    <p><b><u>Pathophysiology</u></b>: plaque ruptures, thrombus causing new partial occlusion (no infarct)</p>
    <p><b><u>Treatments</u></b>: aspirin, nitrates, &beta;&#x2011;blockers, statins</p>
    <div class="ind arrows">
        &#8627;&nbsp;Aspirin as blood-thinner to reduce chance of clotting<br>
        &#8627;&nbsp;Nitrates are smooth muscle relaxants &Rightarrow; vasodilation<br>
        &#8627;&nbsp;&beta;&#x2011;blockers to decrease HR and contractility &Rightarrow; &darr; cardiac output and O<sub>2</sub> consumption<br>        
        &#8627;&nbsp;Statins to lower LDL<br>
    </div>

    <h3 id="vasospastic">Prinzmetal (vasospastic) Angina</h3>

    <h2 id="mi">Myocardial Infarction (MI)</h2>
    <h3 id="stemi">ST-segment elevation myocardial infarction</h3>
    <h3 id="nstemi">Non-ST-segment elevation myocardial infarction</h3>
    
    <h2 id="hf">Heart Failure</h2>
    <p><b>Heart failure</b> (also called <b>congestive heart failure</b>, HF or CHF) is defined as the inability of the heart to generate sufficient cardiac output (CO) to meet the metabolic demands of the body. It is the a syndrome or diagnosis, not a specific disease. HF can divided as divided as follow:</p>
    <ul>
        <li>Left-sided heart failure
            <ul>
                <li>Heart failure with reduced ejection fraction (HFrEF)</li>
                <li>Heart failure with preserved ejection fraction (HFpEF)</li>
            </ul>
        </li>
        <li>Right-sided heart failure</li>
    </ul>

    <h3 id="lhf">Left-sided Heart Failure</h3>
    <h3 id="rhf">Right-sided Heart Failure</h3>
    <p>The <u>most commmon cause of RHF</u> is <u>LHF</u>. Other causes include cor pulmonale (RHF due to pulmonary HTN) and pulmonary or tricuspid valve disease.</p>

    <h2 id="athero">Atherosclerosis</h2>
    
    <br>

    <h2>References</h2>
    <ol>
        <li>First Aid for the USMLE Step 1 2020</li>
        <li>First Aid for the Basic Sciences - Organ Systems</li>
        <li>AMBOSS Library</li>
    </ol>
</body>
</html>